Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             136 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD Matar, Michael A.
 2009
 19 Supplement 3 p. 283-295
13 p.
 artikel
2 Antipsychotic effects on auditory sensory gating in schizophrenia patients Sánchez-Morla, Eva María
 2009
 19 Supplement 3 p. 905-909
5 p.
 artikel
3 Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients Shiloh, Roni
 2009
 19 Supplement 3 p. 654-658
5 p.
 artikel
4 Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study Dell'Agnello, Grazia
 2009
 19 Supplement 3 p. 822-834
13 p.
 artikel
5 C.06.04 Can switching antipsychotics improve patient outcomes? Falkai, P.
 2009
 19 Supplement 3 p. S711-
1 p.
 artikel
6 C.14.01 Ensuring data quality in multi-national clinical trials Höschl, C.
 2009
 19 Supplement 3 p. S717-
1 p.
 artikel
7 C.01.01 Importance of a good night's sleep Williams, A.
 2009
 19 Supplement 3 p. S705-
1 p.
 artikel
8 Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate Trezza, Viviana
 2009
 19 Supplement 3 p. 659-669
11 p.
 artikel
9 Contents 2009
 19 Supplement 3 p. OBC-
1 p.
 artikel
10 C.03.01 Serotonergic dysfunction – implications for treatment of mood and anxiety disorders Blier, P.
 2009
 19 Supplement 3 p. S706-
1 p.
 artikel
11 Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells Park, Sung Woo
 2009
 19 Supplement 3 p. 356-362
7 p.
 artikel
12 Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose Peles, Einat
 2009
 19 Supplement 3 p. 581-588
8 p.
 artikel
13 ECNP Announcement: 2010 ECNP Workshop 2009
 19 Supplement 3 p. IV-
1 p.
 artikel
14 ECNP Calendar of Events 2009
 19 Supplement 3 p. III-
1 p.
 artikel
15 ECNP Calendar of Events 2009
 19 Supplement 3 p. I-
1 p.
 artikel
16 Editorial Board 2009
 19 Supplement 3 p. IFC-
1 p.
 artikel
17 Editorial Board 2009
 19 Supplement 3 p. IFC-
1 p.
 artikel
18 Effects of risperidone on glutamate receptor subtypes in developing rat brain Choi, Yong Kee
 2009
 19 Supplement 3 p. 77-84
8 p.
 artikel
19 E.06.02 Process of development of the ICD-11 and DSM-V: first results and cultural perspectives Sartorius, N.
 2009
 19 Supplement 3 p. S223-
1 p.
 artikel
20 Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study Pae, Chi-Un
 2009
 19 Supplement 3 p. 562-570
9 p.
 artikel
21 Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice Mechanic, Jordan A.
 2009
 19 Supplement 3 p. 466-475
10 p.
 artikel
22 Keyword Index 2009
 19 Supplement 3 p. S171-
1 p.
 artikel
23 Objective: remission of depression in primary care Ansseau, Marc
 2009
 19 Supplement 3 p. 169-176
8 p.
 artikel
24 P.1.a.002 Association study of −1727 A/T and −50C/T GSK-3 beta gene polymorphism with suicidal behaviour in depressed patients Yoon, H.K.
 2009
 19 Supplement 3 p. S225-S226
2 p.
 artikel
25 P.1.a.013 Association study of cannabinoid receptor gene with olanzapine-induced weight gain in schizophrenia Kang, S.G.
 2009
 19 Supplement 3 p. S232-S233
2 p.
 artikel
26 P.1.31 Abelson helper integration site 1 and chromosome 6 open reading frame 217 genes in schizophrenia and bipolar disorder Slonimsky, A.
 2009
 19 Supplement 3 p. S27-S28
2 p.
 artikel
27 P.7.a.003 Efficacy of prolonged-release methylphenidate in a randomized controlled trial in adults with ADHD: secondary endpoints Schaeuble, B.
 2009
 19 Supplement 3 p. S679-S680
2 p.
 artikel
28 P.2.a.023 Gender differences in symptoms and comorbidity patterns in Dutch depressive outpatients: the Leiden Routine Outcome Monitoring (ROM) Study van der Wee, N.
 2009
 19 Supplement 3 p. S373-S374
2 p.
 artikel
29 P.4.a.006 Internet-based screening of anxiety disorders Van Ameringen, M.
 2009
 19 Supplement 3 p. S588-S589
2 p.
 artikel
30 P.1.a.016 Negative life events and genes of the serotonergic pathway of suicide victims with previous aggressive behaviour Pregelj, P.
 2009
 19 Supplement 3 p. S234-S235
2 p.
 artikel
31 P.8.a.004 Pharmacological treatment prescribed to emergency psychiatric patients over 65 years Arcega, J.
 2009
 19 Supplement 3 p. S695-S696
2 p.
 artikel
32 P.3.12 Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart review Paba, S.
 2009
 19 Supplement 3 p. S71-S72
2 p.
 artikel
33 P.4.06 Aripiprazole impact on methamphetamine i.v. self-administration in the olfactory-bulbectomy model of depression in rats Kucerova, J.
 2009
 19 Supplement 3 p. S84-S85
2 p.
 artikel
34 P.3.a.009 Schizophrenia Related NRG1 single nucleotide polymorphisms Lead to Smooth Eye Pursuit Dysfunction in a population of young men Smyrnis, N.
 2009
 19 Supplement 3 p. S485-
1 p.
 artikel
35 P.4.a.003 Sex differences in susceptibility to adverse effects of prenatal stress on birth weight: study of 2516 Belgrade newborns Dunjic, B.
 2009
 19 Supplement 3 p. S587-
1 p.
 artikel
36 P.2.a.006 Sexual function in depressed outpatients with enduring personality change (F62.0) taking mirtazapine Stojakovic, M.
 2009
 19 Supplement 3 p. S364-
1 p.
 artikel
37 P.3.09 Association of circadian salivary cortisol and cognitive function in patients with major depression Hinkelmann, K.
 2009
 19 Supplement 3 p. S69-S70
2 p.
 artikel
38 P.2.a.020 The catechol-O-methyltransferase gene might be associated with males major depression Huang, S.Y.
 2009
 19 Supplement 3 p. S371-S372
2 p.
 artikel
39 P.2.a.037 The efficacy and safety of milnacipran 50 mg bid in patients with major depression: the results of a clinical trial Gogus, A.
 2009
 19 Supplement 3 p. S381-S382
2 p.
 artikel
40 P.3.a.023 What do large scale studies of medication in schizophrenia add to our management strategies? Agius, M.
 2009
 19 Supplement 3 p. S493-
1 p.
 artikel
41 P.3.a.026 Ziprasidone switching effects on metabolic syndrome in patients treated with others atypical antipsychotics Grigorescu, R.
 2009
 19 Supplement 3 p. S495-
1 p.
 artikel
42 P.3.b.01l Dysfunction of configural face processing in individuals at ultra-high risk for schizophrenia Kim, H.S.
 2009
 19 Supplement 3 p. S509-
1 p.
 artikel
43 P.4.b.00l Endocannabinoids modulate the flight responses induced by a nitric oxide donor in the dorsolateral periaqueductal gray Lisboa, S.F.
 2009
 19 Supplement 3 p. S596-S597
2 p.
 artikel
44 P.2.b.012 Long-term neurobiological changes by chronic mild stress and residual alterations after antidepressant discontinuation Elizalde, N.
 2009
 19 Supplement 3 p. S397-S398
2 p.
 artikel
45 P.7.b.004 Neurobiological correlates of disruptive behaviour disorder in a normal population; differences between boys and girls Platje, E.
 2009
 19 Supplement 3 p. S685-S686
2 p.
 artikel
46 P.7.b.007 Neurobiological factors as predictors for re-offending in adolescent males Vries-Bouw, M. De
 2009
 19 Supplement 3 p. S687-
1 p.
 artikel
47 P.5.b.002 Plasma levels of monocyte chemotactic protein 3 and beta-nerve growth factor increase in patients with amnestic mild cognitive impairment (MCI) Park, S.
 2009
 19 Supplement 3 p. S625-S626
2 p.
 artikel
48 P.3.b.001 Predictors of social functioning in schizophrenia Erol, A.
 2009
 19 Supplement 3 p. S503-
1 p.
 artikel
49 P.6.b.001 The galanin-3 antagonist, SNAP37889, reduces preference for operant-responding for ethanol in alcohol-preferring iP rats Djouma, E.
 2009
 19 Supplement 3 p. S643-
1 p.
 artikel
50 P.1.b.004 Ultradian regulations: relationships between sleep EEG power spectra and REM-NREM sleep cycles Neu, D.
 2009
 19 Supplement 3 p. S242-S243
2 p.
 artikel
51 P.4.16 Cannabis use and subclinical psychotic symptoms: is the public mental health at risk? Schubart, C.D.
 2009
 19 Supplement 3 p. S92-S93
2 p.
 artikel
52 P.2.c.040 A randomised, double-blind, placebo-controlled, active-referenced study of Lu AA21004 in patients with major depression Artigas, F.
 2009
 19 Supplement 3 p. S426-S427
2 p.
 artikel
53 P.6.c.007 Association between opioid receptor availability and anxiety in healthy controls but not in substance dependence Williams, T.M.
 2009
 19 Supplement 3 p. S653-S654
2 p.
 artikel
54 P.1.c.048 Brain histamine-3 receptors as a potential target of novel strategies in the treatment of mental disorders Folgering, J.H.A.
 2009
 19 Supplement 3 p. S279-
1 p.
 artikel
55 P.3.c.060 Changes in hyperprolactinaemia and related adverse events after switching antipsychotic treatment to quetiapine Montejo, A.L.
 2009
 19 Supplement 3 p. S544-S545
2 p.
 artikel
56 P.3.c.015 Dose response side effects of risperidone versus convenient antipsychotics Popovic, I.
 2009
 19 Supplement 3 p. S519-
1 p.
 artikel
57 P.3.c.063 Effect of 5-HT1a and catechol-O-methyl-transferase gene polymorphisms on negative symptom response to clozapine Porcelli, S.
 2009
 19 Supplement 3 p. S546-S547
2 p.
 artikel
58 P.1.c.034 Effect of topiramate on valproic acid clearance in adult patients with epilepsy: a population pharmacokinetic study Vucicevic, K.
 2009
 19 Supplement 3 p. S271-
1 p.
 artikel
59 P.2.c.022 Efficacy of trazodone in patients with primary insomnia with and without concomitant depressive symptomatology Wichniak, A.
 2009
 19 Supplement 3 p. S416-
1 p.
 artikel
60 P.1.c.020 Histological outcome after oxcarbazepine treatment in the asphyxiated neonatal rat brain Papazisis, G.
 2009
 19 Supplement 3 p. S263-
1 p.
 artikel
61 P.2.c.036 Increase of 5-HTT occupancy during escitalopram or citalopram treatment correlates with antidepressant efficacy in major depressive disorder Akimova, E.
 2009
 19 Supplement 3 p. S424-S425
2 p.
 artikel
62 P.2.02 Citalopram and venlafaxine in the treatment of depressive disorder in elderly patients Galecki, P.
 2009
 19 Supplement 3 p. S144-S145
2 p.
 artikel
63 P.3.c.046 Long-term safety and maintenance of effect of asenapine in patients with acute exacerbation of schizophrenia Meltzer, H.
 2009
 19 Supplement 3 p. S536-S537
2 p.
 artikel
64 P.1.c.017 Neuropsychiatric adverse drug reactions (ADRs) and neuropsychiatric drugs-induced ADRs in a tertiary care hospital Ponte, M.
 2009
 19 Supplement 3 p. S261-
1 p.
 artikel
65 P.1.14 Compared stereoselectivity of the native and recombinant histamine H3 receptor isoforms Gbahou, F.
 2009
 19 Supplement 3 p. S13-S14
2 p.
 artikel
66 P.1.c.003 Opiates and SSRI's: risk for serotonin syndrome Timmerman, L.
 2009
 19 Supplement 3 p. S252-S253
2 p.
 artikel
67 P.6.c.013 Prodromal symptoms and neurocognitive profile of 3 groups of dependent drug users: cannabis, ketamine and cocaine Morgan, C.
 2009
 19 Supplement 3 p. S657-
1 p.
 artikel
68 P.3.c.029 Results from the monitoring system for clozapine in Slovakia Pecenak, J.
 2009
 19 Supplement 3 p. S527-
1 p.
 artikel
69 P.2.c.031 Safety and tolerability of adjunctive aripiprazole in major depressive disorder: pooled data from 3 short-term studies Loze, J.Y.
 2009
 19 Supplement 3 p. S421-S422
2 p.
 artikel
70 P.2.c.008 Serotonin transporter gene polymorphisms, personality and response to serotonergic and noradrenergic antidepressants Tranter, R.
 2009
 19 Supplement 3 p. S407-S408
2 p.
 artikel
71 P.4.c.005 The cardiovascular effects of a subtype selective and non-selective benzodiazepine agonist in healthy volunteers Bailey, J.E.
 2009
 19 Supplement 3 p. S606-S607
2 p.
 artikel
72 P.2.c.005 Tolerability of combination of low-dose amisulpride with antidepressants in clinical practice Ceskova, E.
 2009
 19 Supplement 3 p. S406-
1 p.
 artikel
73 P.3.c.012 Use of atypical antipsychotic determines good compliance to medication in a teaching hospital in Malaysia Zainal, N.Z.
 2009
 19 Supplement 3 p. S517-
1 p.
 artikel
74 P6.d.008 CB1 receptors are involved in some but not all nicotine-motivated behaviours Wing, V.C.
 2009
 19 Supplement 3 p. S661-S662
2 p.
 artikel
75 P.2.d.009 Differential effects of fluoxetine or venlafaxine treatment on maternal separation, an experimental model of depression Martisova, E.
 2009
 19 Supplement 3 p. S434-S435
2 p.
 artikel
76 P.3.d.016 Effect of olanzapine on MK-801-induced impairment of memory in the radial-arm maze test in mice Komsuoglu, I.
 2009
 19 Supplement 3 p. S563-
1 p.
 artikel
77 P.1.04 Depression-like behaviour and reduced levels of the serotonin reuptake transporter in the brain regions of NCAM deficient mice Aonurm-Helm, A.
 2009
 19 Supplement 3 p. S133-S134
2 p.
 artikel
78 P.2.d.032 Glycogen synthase kinase 3 (GSK-3β) an emerging target for neurological disease: in silico study to investigate the binding mode of trazodone Ombrato, R.
 2009
 19 Supplement 3 p. S447-S448
2 p.
 artikel
79 P.3.d.002 Hyperglycemia and antipsychotic treatment in patients on methadone maintenance Barbadillo, L.
 2009
 19 Supplement 3 p. S554-S555
2 p.
 artikel
80 P6.d.01l Comparison of behavioural consequences pre and postnatal morphine exposure in the rats offspring Gyarmati, Z.
 2009
 19 Supplement 3 p. S663-S664
2 p.
 artikel
81 P.1.d.013 Prenatal stress increases an anxiety, and alters corticosterone response to 5-HT2A/C agonist in adult female offspring Ordyan, N.
 2009
 19 Supplement 3 p. S294-S295
2 p.
 artikel
82 P.2.d.023 Synergic mechanisms in the modulation of BDNF and Arc following agomelatine administration Calabrese, F.
 2009
 19 Supplement 3 p. S442-S443
2 p.
 artikel
83 P.2.d.026 The role of GIRK channels on the inhibitory effect of antidepressants on noradrenergic neurotransmission Torrecilla, M.
 2009
 19 Supplement 3 p. S444-
1 p.
 artikel
84 P.2.e.017 Aripiprazole combination with divalproex in patients with acute manic and mixed episode Bahk, W.
 2009
 19 Supplement 3 p. S458-
1 p.
 artikel
85 P.5.e.005 Charles Bonnet Syndrome: a conceptual revision and review of a case report Vazquez, M. Serrano
 2009
 19 Supplement 3 p. S633-S634
2 p.
 artikel
86 P.3.e.006 Diagnostic stability of schizophrenia in Korean patients according to the DSM-IV Kim, W.
 2009
 19 Supplement 3 p. S570-S571
2 p.
 artikel
87 P.3.e.020 Early medication adherence and insight change in first episode psychosis Lepage, M.
 2009
 19 Supplement 3 p. S578-S579
2 p.
 artikel
88 P.2.27 Effects of nicotine and ethanol on social play behaviour in adolescent rats Trezza, V.
 2009
 19 Supplement 3 p. S55-S56
2 p.
 artikel
89 P.1.e.023 Longitudinal assessment of presynaptic dopamine function in the striatum: a [18]F-DOPA PET test-retest study Egerton, A.
 2009
 19 Supplement 3 p. S313-S314
2 p.
 artikel
90 P.1.e.008 Methylphenidate modulates inferior and orbitofrontal brain activation in ADHD during sustained attention and reward Rubia, K.
 2009
 19 Supplement 3 p. S304-S305
2 p.
 artikel
91 P.2.e.003 Mixed symptoms of bipolar disorder related to nicotine dependence but not current smoking in young men Yeh, C.B.
 2009
 19 Supplement 3 p. S449-S450
2 p.
 artikel
92 P.2.e.034 Personality disorder comorbidity among outpatients with bipolar disorder: impact on prognosis and quality of life Frikha, A.
 2009
 19 Supplement 3 p. S468-
1 p.
 artikel
93 P.4.e.005 Personality factor and defense mechanism of non-offensive and offensive type of social phobia patients in Korea Baek, S.B.
 2009
 19 Supplement 3 p. S615-
1 p.
 artikel
94 P.1.e.005 Reduced activation and functional interconnectivity within fronto-striatal systems in adults with childhood ADHD Cubillo, A.
 2009
 19 Supplement 3 p. S302-S303
2 p.
 artikel
95 P.4.e.008 The factors that influence the therapeutic response to paroxetine in patients with panic disorder: longitudinal study Ueda, M.
 2009
 19 Supplement 3 p. S617-
1 p.
 artikel
96 P.3.e.003 The relative association between four treatment-emergent adverse events and health-related quality of life Ruiz, I.
 2009
 19 Supplement 3 p. S568-S569
2 p.
 artikel
97 P.6.e.005 Validation study of Kim's smoking cessation motivation scale and its predictive implications for smoking cessation Park, J.W.
 2009
 19 Supplement 3 p. S671-S672
2 p.
 artikel
98 P.5.f.003 Loss of NPC1-deficient neurons is associated with altered mevalonate pathway regulation Ohm, T.
 2009
 19 Supplement 3 p. S635-
1 p.
 artikel
99 P.1.g.004 Developing assessment tool of competency to consent to psychiatric admission treatment in the mentally ill Kim, S.
 2009
 19 Supplement 3 p. S322-S323
2 p.
 artikel
100 P.2.g.008 Effects of lemon and valerian inhalation on autonomic nerve activity in depressed and healthy subjects Komori, T.
 2009
 19 Supplement 3 p. S475-S476
2 p.
 artikel
101 P.2.g.011 Painful physical symptoms in major depressive Turkish outpatients Karamustafalioglu, O.
 2009
 19 Supplement 3 p. S477-
1 p.
 artikel
102 P.1.h.001 Delayed sleep phase syndrome in burn patients Lee, B.C.
 2009
 19 Supplement 3 p. S331-
1 p.
 artikel
103 P.1.i.001 A year in the psychiatric clinic of general hospital Thriasio; statistical analysis of the patients characteristics Neroutsos, E.
 2009
 19 Supplement 3 p. S336-S337
2 p.
 artikel
104 P. 1.i.004 Characterization of conditioned fear-induced c-Fos and phosphorylated CREB-positive cells in the basolateral amygdala Izumi, T.
 2009
 19 Supplement 3 p. S338-
1 p.
 artikel
105 P.1.i.018 Clinical semantics, semiology and auto-evaluation. The challenging case of fatigue and sleepiness Neu, D.
 2009
 19 Supplement 3 p. S346-S347
2 p.
 artikel
106 P.1.i.038 Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder Lasser, R.
 2009
 19 Supplement 3 p. S356-
1 p.
 artikel
107 P.4.02 Influence of drugs with anxiolytic properties on serotonergic receptors in the rat brain Kowalczyk, M.
 2009
 19 Supplement 3 p. S157-S158
2 p.
 artikel
108 P.1.i.035 Objective and subjective efficacy of ramelteon 4mg in adults with chronic insomnia Hajak, G.
 2009
 19 Supplement 3 p. S354-S355
2 p.
 artikel
109 P.l.c.058 Evaluation of an inpatient therapeutic interchange protocol for second generation antidepressants and clinical follow-up Martínez-Granados, F.
 2009
 19 Supplement 3 p. S284-S285
2 p.
 artikel
110 P.l.c.06l Effects of repeated citalopram treatment on the kainic acid induced alterations in brain plasticity in adult mouse Jaako, K.
 2009
 19 Supplement 3 p. S286-
1 p.
 artikel
111 P.l.c.044 Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brain Tyacke, R.J.
 2009
 19 Supplement 3 p. S276-S277
2 p.
 artikel
112 P.2.10 Neuropeptide Y modulation of the gluta-matergic system in the Flinders Sensitive Line rat: a rat model of depression Hascup, K.N.
 2009
 19 Supplement 3 p. S41-S42
2 p.
 artikel
113 P.2.13 Opioidergic modulation of reward anticipation in the human brain Mehta, M.A.
 2009
 19 Supplement 3 p. S44-
1 p.
 artikel
114 P.1.07 Prodrugs of 3-hydroxy-7-brom-5-phenyl- 1,4-benzdiazepin-2-on for oral delivery Kravchenko, I.
 2009
 19 Supplement 3 p. S135-S136
2 p.
 artikel
115 P.3.07 Quality of life of family members of patients with first episode psychosis and family-centered treatment Reinson, L.
 2009
 19 Supplement 3 p. S155-S156
2 p.
 artikel
116 Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro Amit, Ben Hayman
 2009
 19 Supplement 3 p. 726-734
9 p.
 artikel
117 P.8.02 The hydrolysis of 7-bromo-3-hydroxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one esters by pig liver microsomes Romanovskaya, I.I.
 2009
 19 Supplement 3 p. S166-S167
2 p.
 artikel
118 P.1.01 The kinurenine pathway gene polymorphisms of the tryptophan metabolism do not play a role in Alzheimer's disease Juhasz, A.
 2009
 19 Supplement 3 p. S131-
1 p.
 artikel
119 P.1.17 The study of personality traits variation in gene–gene and gene–environment interactions context Kazantseva, A.
 2009
 19 Supplement 3 p. S16-S17
2 p.
 artikel
120 Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex Maćkowiak, Marzena
 2009
 19 Supplement 3 p. 125-137
13 p.
 artikel
121 S.12.04 Aging-related decline in relational/declarative and working memory: a translational approach from mice to humans Marighetto, A.
 2009
 19 Supplement 3 p. S195-
1 p.
 artikel
122 S.24.03 Amyloid plaque imaging in vivo Seibyl, J.
 2009
 19 Supplement 3 p. S211-S212
2 p.
 artikel
123 S.16.05 Animal models of cognitive flexibility Granon, S.
 2009
 19 Supplement 3 p. S200-
1 p.
 artikel
124 S.07.06 Aripiprazole and risperidone improve working memory in healthy volunteers; an fMRI study Murphy, A.
 2009
 19 Supplement 3 p. S188-S189
2 p.
 artikel
125 S.2.01 Can PTSD be prevented? Strategic interventions in the ‘golden hours’ Zohar, J.
 2009
 19 Supplement 3 p. S111-S113
3 p.
 artikel
126 S.03.01 Do virus infections cause schizophrenia? Karlsson, H.
 2009
 19 Supplement 3 p. S178-
1 p.
 artikel
127 S.1.02 Engineering receptor subtypes as tools in neuropsychopharmacology Wisden, W.
 2009
 19 Supplement 3 p. S2-S3
2 p.
 artikel
128 S.21.01 Introduction: recent finding from ongoing NIMH studies Vitiello, B.
 2009
 19 Supplement 3 p. S206-S207
2 p.
 artikel
129 S.17.04 Oxytocin and social behaviour: implications for psychotherapy Heinrichs, M.
 2009
 19 Supplement 3 p. S201-
1 p.
 artikel
130 S.28.03 Serotonin control over neuronal migration Dayer, A.
 2009
 19 Supplement 3 p. S216-
1 p.
 artikel
131 S.04.06 The role of serotonin in memory-related cortices for cocaine-induced place preference and hyperlocomotion Muller, C.P.
 2009
 19 Supplement 3 p. S182-
1 p.
 artikel
132 S.26.03 Translational imaging in the development of psychopharmacological drugs Bifone, A.
 2009
 19 Supplement 3 p. S212-S213
2 p.
 artikel
133 S.05.01 Understanding individual variability in response: a review of the evidence Leucht, S.
 2009
 19 Supplement 3 p. S183-
1 p.
 artikel
134 Tic hydantoin sigma-1 agonist: Pharmacological characterization on cocaine-induced stimulant and appetitive effects Toussaint, Marion
 2009
 19 Supplement 3 p. 504-515
12 p.
 artikel
135 Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study Novick, Diego
 2009
 19 Supplement 3 p. 542-550
9 p.
 artikel
136 Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study Avital, Ayelet
 2009
 19 Supplement 3 p. 476-482
7 p.
 artikel
                             136 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland